在慢性冠状动脉疾病管理中的关键文章和指导方针
Dave L Dixon1, Tomasz Jurga2, Michael Kelly3
1Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA.
Journal of pharmacy practice
|October 30, 2025
概括
心血管事件管理方面的进步导致更多的患者需要为慢性冠状动脉疾病 (CCD) 提供慢性护理. 新的指导方针和药物治疗对于预防这些患者未来的心脏事件至关重要.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 临床实践指南 临床实践指南
背景情况:
- 心血管疾病是导致死亡的主要原因.
- 改善急性事件管理增加了需要慢性护理的人口.
- 稳定的缺血性心脏病 (SIHD) 现在被称为慢性冠状动脉疾病 (CCD).
研究的目的:
- 总结了慢性冠状动脉疾病 (CCD) 管理的关键文章和指南.
- 为照顾CCD患者的临床医生提供资源.
- 突出药物治疗在CCD中的扩大作用.
主要方法:
- 审查最近的临床试验和新药疗法.
- 巩固关于二次预防和SIHD管理的先前指南.
- 综合证据影响CCD的药物治疗.
主要成果:
- 2023年CCD指南巩固了之前的建议.
- 药物治疗在CCD管理中发挥着越来越重要的作用.
- 新出现的证据支持CCD的扩大治疗选择.
结论:
- 临床医生需要更新的资源来管理慢性冠状动脉疾病.
- 药物治疗是CCD中二次预防的基石.
- 遵守最新的指导方针对于最佳的患者结果至关重要.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome V: Nursing Management
619
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
619
Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


